Correction: Overview of the current use of levosimendan in France: a prospective observational cohort study
Annals of Intensive Care volume 13, Article number: 94 (2023)
Correction: Annals of Intensive Care (2023) 13:69 https://doi.org/10.1186/s13613-023-01164-3
In the original publication of the article , ARCOTHOVA study group Collaborators’ member name Nicolas Nesseler was incorrectly written as Nicolas Nessler. The original article has been corrected.
Cholley B, Bojan M, Guillon B, Besnier E, Mattei M, Levy B, Ouattara A, Tafer N, Delmas C, Tonon D, Rozec B, Fellahi J-L, Lim P, Labaste F, Roubille F, Caruba T, Mauriat P, for the ARCOTHOVA study group. Overview of the current use of levosimendan in France: a prospective observational cohort study. Ann Intensive Care. 2023;13:69. https://doi.org/10.1186/s13613-023-01164-3.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Cholley, B., Bojan, M., Guillon, B. et al. Correction: Overview of the current use of levosimendan in France: a prospective observational cohort study. Ann. Intensive Care 13, 94 (2023). https://doi.org/10.1186/s13613-023-01193-y